"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demand

The net in casting on June 25 message, home's banner auxiliary save trouble serves a provider " reproduction of bright and beautiful glad " land harbor to reach place now, release price 8.54 HK dollar yuan. After open quotation, share price all the way raise 17.01% , total market prise twenty-three billion eight hundred and eight million yuan.

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

Public data shows, reproduction of bright and beautiful glad is supplier of home's banner auxiliary reproduction service, treat only infecund not Yo. If benefit article report shows Sitesha,not, 2018, reproduction of bright and beautiful glad already became Chinese country's biggest civilian run to assist reproduction to serve an orgnaization, market share is about 3.1% , HRC Fertility of the United States below the banner has 30 old history, in the United States western the market is ranked the first.

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

Current, the auxiliary reproduction service that reproduction of bright and beautiful glad provides basically comprises by two kinds of technologies: Test-tube with test tube baby (IVF) , and IVF technology already was applied extensively.

The market demands exceeds supply, bright and beautiful glad earns 1 billion one year

This is one is had quite " masses foundation " industry. 1978, since baby of the first tube is born, the number year after year that the whole world is born through technology of test tube baby is climbed litre. July 2018, international assists the report that committee of birth technology monitoring issues to show, since 1978, the whole world already had the world of advent of baby of more than 8 million tube. The test tube baby that at present the whole world carries out every year treats cycle to exceed 2 million, the infantile number that bears successfully every year through this technology already exceeded 500 thousand. Professional periodical article anticipates, to 2100, technology of external fertilization of have the aid of (IVF) the 3.5 % that birth number will reach global total population possibly (about 400 million person) .

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

In the listen dispatch data of reproduction of bright and beautiful glad also cite relevant data -- the sicken of infecund disease leads the whole world from 1977 11% rise to 15% 2017, among them China also was achieved 2017 15.5% , this is meant, china had couple of 47.7 million pairs of infecund disease about 2017.

Then, ten million is infecund not Yo couple also brought several yuan business to reproduction of bright and beautiful glad. Book of raise capital by floating shares shows, 2016 to 2018, income of implementation of medical treatment of bright and beautiful glad is 346 million yuan respectively, 663 million yuan, 922 million yuan, compound increase rate exceeds 50% . Was 133 million yuan respectively to the wool profit 2018 2016, 302 million yuan mix 413 million yuan, corresponding wool interest rate is respectively 38.3% , 45.6% with 44.8% .

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

On specific income composition, the accrual of reproduction of bright and beautiful glad basically comes from auxiliary reproduction service, government service and service of auxiliary medical treatment. This among them, auxiliary reproduction service is the greatest to the contribution of company outstanding achievement, administrative service and service of auxiliary medical treatment are relatively lesser.

With was 2018 exemple, the auxiliary reproduction service revenue 2018 is as high as reproduction of bright and beautiful glad 801 million yuan (RMB, similarly hereinafter) , occupy mediumly in business gross income than for 86.9% ; Manage service revenue 90 million yuan, occupy than 9.7% , service revenue of auxiliary medical treatment 31 million yuan, occupy than 3.4% .

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

However, home's existing auxiliary reproduction technology and orgnaization cannot satisfy the market demand with swift and violent growth. March 2016 portion, the country allows to defend unripe family planning when appoint vice director Ma Xiaowei ever introduced, the auxiliary reproduction orgnaization that Chinese classics approves year all complete 700 thousand auxiliary birth operations. Apparent, opposite 40 million infecund not Yo patient amount, the market is in the condition that demands exceeds supply badly. This is brought about directly operation of baby of tube of city of a gleam of waits in Beijing, Shanghai, the patient needs on average to queue up 6 months above.

Market gap is huge, in the auxiliary reproduction market that can give priority to in public hospital base oneself upon, reproduction of bright and beautiful glad is very not easy. Strung closes in competition, reproduction of bright and beautiful glad is written so in book of raise capital by floating shares, "Auxiliary reproduction of China serves the market, we basically reach hospital of reproductive specialized subject and competition of a few private medical establishment with integrated and public hospital, and be in the United States, we basically compete with clinic of service of private and auxiliary reproduction " . The market of two countries is relatively split still nevertheless, "The participator of 5 big markets of each market takes egg Zuo period number by the IVF that undertook 2017 plan occupy inadequacy respectively 20% reach the market share of 15% " , this also brought the possibility of break out of an encirclement to reproduction of bright and beautiful glad.

Inchoative Sichuan, sino-US two countries makes money

Iatrical of bright and beautiful glad founds the earliest but date from comes 2003, senior doctor and administrative group establish many industry IVF center, basically offer auxiliary reproduction medical treatment and item of other and relevant cure, through the development of period of time, be in at present group of hospital of accessary subsidiary Xi Nan and Shenzhen Zhongshan hospital are passed to provide the relevant service such as auxiliary reproduction, management, medical treatment in home.

Public data shows, reproduction of bright and beautiful glad issues reproduction, provide for the aged, medical treatment for division of group of bright and beautiful glad Wu of 3 great undertaking board piece one of, hold water at opening graceful archipelago to register on May 3, 2018, the affiliated company that passes China and United States begins auxiliary reproduction and administrative service.

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

Up to by May 2019, reproduction of bright and beautiful glad has hospital of department of gynaecology of Chengdu Xi Nan, Chengdu hospital of hospital of new and high Xi Nan, surgery of make water of Shenzhen Zhongshan secrete, return joint operation Chengdu additionally center of reproduction of courtyard of health care of women and children of area of bright and beautiful river. In addition, reproduction of bright and beautiful glad still is passed and buy the share that waits for the American medical establishment such as center of means hold RSA, NexGenomics and HRCMedical.

Then, although be a of Chinese southwest civilian look forward to, sino-US two ground are reproduction of bright and beautiful glad however construct collect field. Such the book of raise capital by floating shares of reproduction of bright and beautiful glad is medium writing, "The market of auxiliary reproduction service of China and United States is split, because assist reproduction to serve popularity rate,inferior, infecund rate increases reach auxiliary reproduction service to supply finite, china offerred tremendous opportunity to assist reproduction to serve a supplier. In the meantime, the United States serves the market to provide the auxiliary reproduction of appeal, the auxiliary reproduction that offers comprehensive, maturity and high end serves. There is the banner place of the market in China and United States by right of us, can serve auxiliary reproduction of my China and United States the growth opportunity that the patient is contented demand and two ground market. Can serve auxiliary reproduction of my China and United States the growth opportunity that the patient is contented demand and two ground market..

Reach place according to harbor newest collection of the data after the listen dispatch that announce (full text archives) show, reproduction of bright and beautiful glad undertook in domestic accumulative total 20958 IVF treat cycle 2018, home is ranked the 3rd; The corresponding period undertook in the United States 4500 IVF treat cycle, the rank western also ranks the United States the first.

Hua Ping, Chinese larch, tall Ling enter bureau

Appear on the market this, investor of 4 big foundation stone adds up to invest 150 million dollar to be reproduction of bright and beautiful glad " platform " , it is tall Ling capital respectively (70 million dollar) , Ao Bo capital (30 million dollar) , the capital that collect the bridge (30 million dollar) with Cormorant (20 million dollar) , can of cornerstone investor a group of people of same interest says luxurious.

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

CVSource is cast in data shows, september 2018, reproduction of bright and beautiful glad ever completed strategic investment one round, the Hua Ping investment, investment that believe silver is gotten cast, ming Kangde of Chinese larch capital, medicine with cast, specific financing amount was not announced when those.

"Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demands exceeds supply

Dan Huaping invests to disclose to the net in casting, 2017 second half of the year, hua Ping invested to had undertaken investing for the first time to reproduction of bright and beautiful glad, will get again in September 2019 those who cast reproduction of bright and beautiful glad is new round of financing. Regard reproduction of bright and beautiful glad as the biggest orgnaization investor, hua Ping invested to had invested several dollars to reproduction of bright and beautiful glad, after IPO, occupy 18.77% .

In Hua Ping investment looks, "The market that auxiliary reproduction is a high demand, fast growth, high threshold. On one hand, carry out in the round as 2 embryoes policy, birth demand is exuberant with each passing day, consumer is right auxiliary iatrical acknowledge and accept degree to also rise gradually, market dimensions expands ceaselessly, on the other hand, the specialized subject talent of relevant industry still relatively rare be short of and superintend strict. And reproduction of bright and beautiful glad is to assist the minority in reproductive market to possess admittance qualification already, the medical treatment that again aptitude offers high quality, individuation to serve serves one of orgnaizations. The medical treatment that again aptitude offers high quality, individuation to serve serves one of orgnaizations..

Reproduction of bright and beautiful glad appears on the market, chinese larch China is fond of again carry an IPO. Chinese larch China tells the network in casting, reproduction of bright and beautiful glad is this year the company of the 3rd member that Chinese larch China appears on the market, also be the medical treatment enterprise that its come to the 11st nearly 3 years appear on the market. "Medical treatment health regards Chinese larch China as 4 large investment board piece one of, no matter be investment amount or amount, all be in an industry the first a group of people of same interest " , chinese larch China expresses.

The refer investment to reproduction of bright and beautiful glad, yi Bo of Cao of president of Chinese larch China expresses to the net in casting, "As be not public medical establishment, reproduction of bright and beautiful glad besides having common service advantage, have banner technical actual strength infrequently still. Since hold water, the strategic consciousness that the administrative group of bright and beautiful glad has clarity to the development of industry and enterprise all the time and one with be linked together executive force. No matter be business of will auxiliary reproduction,independent operation still marchs international market, bright and beautiful glad goes in industry front row. Company hopeful is passed after appear on the market last inside unripe growth is mixed and buy drive, unplug so that the head prepares in the market of this one billion two hundred and fifteen million seven hundred and fifty-two thousand one hundred and ninety-two class. " (civil / origin of Feng Ying star / the net in casting)

未经允许不得转载:News » "Infecund not Yo " the first IPO: Over or across is Sino-US year earn 1 billion, the market demand